Benzhydrocodone hydrochlorideProduct ingredient for Benzhydrocodone

Name
Benzhydrocodone hydrochloride
Drug Entry
Benzhydrocodone

Benzhydrocodone is a benzylic prodrug of hydrocodone.5 It was developed in an effort to reduce parenteral bioavailability of the active metabolite as a deterrent to abuse.4 Benzhydrocodone is indicated for use in the short-term management of pain. It was first approved by the FDA in February 2018 in combination with acetaminophen under the trade name Apadaz, marketed by KVK Tech and developed by KemPharm.6,7

Accession Number
DBSALT002879
Structure
Synonyms
Benzhydrocodone HCl / Benzhydrocodone hydrochloride
External IDs
KP 201 / KP-201 / KP201